Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Janssen
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 4 ans
A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients with High-risk Smoldering Multiple Myeloma
The primary objective of the study is to demonstrate that siltuximab will delay progression of high-risk SMM as measured by the 1 year progression-free survival (PFS) rate.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Janssen R&D Ireland
Update Il y a 4 ans
roll-over trial for continued TMC278 access
The primary objective of the trial is to provide continued access to TMC278 for subjects who were randomized and treated with TMC278 in the Phase IIb (C204) or Phase III trials (C209 and C215), and wh...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Mark Janssen, MD
Update Il y a 4 ans
Select Stim: Selective Stimulation of the Subthalamic Nucleus in Parkinson's Disease. "A Feasibility Study
In the advanced stages of Parkinson Disease deep brain stimulation of the subthalamic nucleus (STN DBS) is the next therapeutic option. Despite the beneficial motor effects there are impor...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International NV
Update Il y a 4 ans
An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic HCV-1 and HIV-1
The primary objective is to assess the antiviral efficacy of telaprevir, Peg-IFN-alfa-2a, and RBV in HCV-1/HIV-1 coinfected subjects as measured by sustained virologic response (SVR12planned). SVR1...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Wim Janssens, MD. PhD
Update Il y a 4 ans
Azithromycin for Acute Exacerbations Requiring Hospitalization
This project (funded by the IWT-TBM program) will organize a randomized placebo-controlled multicenter intervention trial in 500 COPD patients to study the effectiveness and safety of azit...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Janssen R&D Ireland
Update Il y a 4 ans
An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis Estudio de eficacia, seguridad, tolerabilidad y farmacocinética de 12 semanas de tratamiento con Simeprevir y Daclatasvir en pacientes con infección crónica por el genotipo 1b o 4 del virus de la hepatitis C y con disfunción renal grave o enfermedad renal terminal en hemodiálisis
The primary objective is to evaluate the efficacy (SVR12) of a 12-week treatment regimen containing SMV and DCV in subjects with chronic HCV genotype 1b or 4 infection and either severe renal impairme...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen-Cilag International N.V
Update Il y a 4 ans
Investigation of the safety, tolerability, and efficacy of JNJ-40411813 as an add-on treatment to an antidepressant in patients with depression with anxiety symptoms
To evaluate the efficacy, as assessed by the change from baseline on a 6-item subscale derived from the Hamilton Anxiety Scale (HAM-A6), and overall safety and tolerability of treatment with adjunctiv...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
Update Il y a 4 ans
Number of Doses and Time to Onset Of Pain Relief (Analgesic Effect) Using the IONSYS™ System [Fentanyl Iontophoretic Transdermal System (40 µg)]
To evaluate the precise dosing pattern of IONSYS system use in post operative patients
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Janssen Korea Ltd
Update Il y a 4 ans
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
The purpose of this study is to evaluate the safety and efficacy of Osmotic Release Oral System (OROS) methylphenidate in participants with Attention Deficit Hyperactivity Disorder (ADHD).
Country
None
organs
None
Specialty
None
More information
Man Max 99 years
Janssen Cliag Ltd. C/O Johnson & Johnson PRD
Update Il y a 4 ans
A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS
To determine whether R317573, after multiple dosing over one week, reduces the intensity of an anxiogenic reaction induced by the intravenous (i.v.) administration of cholecystokinin-tetrapeptide (CCK...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
9
10
11
12
13
14
15
16
17
18
Next